Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery

被引:12
|
作者
Schellong, S
Hesselschwerdt, HJ
Paar, WD
von Hanstein, KL
机构
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Div Angiol, D-01307 Dresden, Germany
[2] Orthoped Rehabil Ctr, Bad Krozingen, Germany
[3] Sanofi Aventis Pharma Germany, Dept Med, Berlin, Germany
[4] ALKO Grp, Wiesbaden, Germany
关键词
ultrasonography; orthopedic surgery; venous thromboembolism; low-molecular-weight heparin;
D O I
10.1160/TH05-01-0077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients undergoing major orthopedic surgery are at an increased risk of thromboembolism even after the acute postoperative phase. Therefore, prolonged thromboprophylaxis is currently recommended and widely used. The length of hospital stay after major orthopedic surgery is steadily decreasing and most patients are transferred to specialized rehabilitation centers in the early postoperative phase. Consequently, thromboprophylaxis is usually given during the rehabilitation period. Previously there have been no systematic studies of how many patients with asymptomatic thrombosis are transferred to a rehabilitation center or how many patients develop deep vein thrombosis (DVT) during rehabilitation. In the present study, 238 patients who had undergone major orthopedic surgery were examined by compression ultrasonography on day 1 or 2 and on day 20 of their rehabilitation phase in order to detect asymptomatic proximal DVT. Sonograms were read centrally with blinding to the clinical course of the patients. All patients received standard thromboprophylaxis during the acute postoperative phase. Prolonged thromboprophylaxis with enoxaparin was given during the rehabilitation phase. The mean duration of thromboprophylaxis was 36.8 days. At admission to the rehabilitation center, proximal DVT was identified in 16 patients (6.7%). New proximal DVT at discharge from the rehabilitation center was identified in 3.2% of patients following prolonged thromboprophylaxis with enoxaparin. In conclusion, a considerable percentage of patients with asymptomatic proximal DVT are transferred to rehabilitation centers following major orthopedic surgery. Using prolonged thromboprophylaxis, new proximal DVTs will still develop during rehabilitation, but at a low rate.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 50 条
  • [1] Is low molecular weight heparin enough to prevent the high risk of deep vein thrombosis after major orthopedic surgery?
    Matias, M.
    Kronberga, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 : 180 - 180
  • [2] Prolonged thromboprophylaxis heparin after major abdominal with low molecular weight surgery
    Rasmussen, Morten S.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (05) : 389 - 392
  • [3] Low-molecular-weight Heparin for prolonged thromboprophylaxis after orthopedic and traumatological surgery in geriatrics
    Merkel, D
    Zippel, C
    Rech, P
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 154 - 154
  • [4] Soleal vein dilatation assessed by ultrasonography is an independent predictor for deep vein thrombosis after major orthopedic surgery
    Abe, Kiyoshi
    Yuda, Satoshi
    Yasui, Kenji
    Okubo, Ayumi
    Kobayashi, Chihiro
    Muranaka, Atsuko
    Ohnishi, Hirofumi
    Hashimoto, Akiyoshi
    Teramoto, Atsushi
    Nagoya, Satoshi
    Tsuchihashi, Kazufumi
    Yamashita, Toshihiko
    Takahashi, Satoshi
    Miura, Tetsuji
    [J]. JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 756 - 762
  • [5] Low Molecular Weight Heparin Versus Fondaparinux for Thromboprophylaxis in Abdominal or Major Orthopedic Surgery Patients
    Shorr, A. F.
    Eikelboom, J. W.
    Horblyuk, R. V.
    Menditto, L. A.
    Lunacsek, O. E.
    Franklin, M. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] Thromboprophylaxis with low molecular weight heparin in major orthopedic surgery: a review regarding the time of administration
    Raggini, F.
    Placella, G.
    Pace, V
    Belluati, A.
    Salini, V
    Antinolfi, P.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (04): : 1451 - 1455
  • [7] Low molecular weight heparin for deep vein thrombosis in glioma patients
    Schmidt, F
    Faul, C
    Dichgans, J
    Weller, M
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (10) : 1409 - 1412
  • [8] Low molecular weight heparin for deep vein thrombosis in glioma patients
    Friederike Schmidt
    Christoph Faul
    Johannes Dichgans
    Michael Weller
    [J]. Journal of Neurology, 2002, 249 : 1409 - 1412
  • [9] Low-Molecular-Weight Heparin in the Initial Treatment of Proximal Deep Vein Thrombosis
    Karen Aileen Valentine
    Graham Frederick Pineo
    Russell Douglas Hull
    [J]. Journal of Thrombosis and Thrombolysis, 1997, 4 (3-4) : 345 - 347
  • [10] Efficacy and safety of low molecular weight heparin (enoxaparin) and unfractionated heparin in proximal deep vein thrombosis
    Leizorovicz, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1186 - P1186